The present disclosure relates to hardware and associated techniques for visualizing the vitreous body of a patient's eye during an ophthalmic procedure.
The human eye is filled with a collagen-containing gel referred to as the vitreous body, or simply the vitreous. The vitreous of a healthy eye is transparent, a characteristic that permits light entering the eye through the pupil and lens to pass unobstructed to the retina. Aging, injury, and other changes to eye may cause the vitreous to liquify and thin. Within the vitreous cavity, clumped collagen fiber (“floaters”) can cast shadows on the retina. Thus, floaters can adversely affect vision depending on their size, quantity, and location within the vitreous chamber.
In order to properly identify and ultimately treat floaters, a clinician may illuminate the vitreous chamber and view the vitreous in real-time through a set of optics. However, as floaters are largely phase objects that typically absorb only 1-2% of incident light, floaters are notoriously difficult to distinguish with trans-corneal, trans-pupillary illumination. For instance, problematic glare can result from the scattering and reflection of incident light from the cornea, natural lens, or intraocular lens (IOL), or from vitreous. Furthermore, endo-illumination and epi-illumination employs a relatively narrow beam and non-uniform lighting. Both characteristics are suboptimal when visualizing the vitreous.
Disclosed herein is a transscleral illumination system and associated control and implementation methodology for visualizing the vitreous of a patient's eye, e.g., during or in preparation for ophthalmic procedures such as laser vitreolysis or vitrectomy surgery. The solutions described herein may be used during an interactive real-time visualization by a clinician, possibly in conjunction with a slit-lamp, in order to afford the clinician with a true dark field view of the patient's vitreous. Unlike the above-summarized trans-corneal, trans-pupillary method, the present approach uniformly illuminates the vitreous chamber by directing light through the sclera and choroid at the ciliary body or pars plana region of the eye as opposed to, e.g., through the cornea, pupil, and lens/IOL.
Illumination is provided by a set of light-emitting diodes (LEDs) or other suitable light emitters. This occurs specifically at or along the pars plana region as noted above, with precise placement of the light emitters being accomplished by an ophthalmic assembly. As part of the disclosed assembly, a tapered/skirt-like portion or flange is connected to or formed integrally with an annular body. The flange circumscribes the cornea and rest directly on the conjunctiva over the sclera.
In particular, an ophthalmic visualization tool is disclosed herein for visualizing a vitreous body within a patient's eye. A non-limiting exemplary embodiment of the visualization tool includes a frame and a light emitter. The frame may include an annular body configured to support an optical lens for viewing the vitreous body, and a flange that is connected to the annular body. The flange has first and second ends. The first end is connected to the frame. The second end is configured to rest on a scleral surface of the eye proximate a pars plana region thereof. The light emitter in this implementation is connected to the flange proximate the second end, and configured to direct light through the scleral surface and into a vitreous cavity of the eye. This occurs at the pars plana region, and has the benefit of uniformly illuminating the vitreous body, as well as eliminating scattered light and reflections that would otherwise occur if illuminating through the cornea, lens, or IOL as noted above.
The annular body could include a set of tabs configured to engage a perimeter edge of the optical lens, with the optical lens possibly being part of the tool.
The first end of the flange, which may have a frustoconical shape, is connected to the annular body. The second end is configured to rest on the scleral surface.
The light emitter in one or more implementations of the tool may include a plurality of LEDs, which in turn may include one or more blue LEDs. At least one of the LEDs is connected to an optical fiber in accordance with certain aspects of the disclosure. The LEDs could also be arranged in a fiber bundle and connected to a plurality of optical fibers.
Also disclosed herein is a transscleral illumination system for visualizing a vitreous body within a patient's eye. The system may include an ophthalmic visualization tool having a frame configured to support an optical lens, as well as a flange having a first end and a second end. As noted above, the first end is connected to the frame. The second end is configured to rest on a scleral surface of the eye proximate a pars plana region thereof. A light emitter is connected to the flange proximate the second end, and configured to direct light through the scleral surface and into a vitreous cavity of the eye. As with the prior-summarized embodiment of the tool, this occurs at the pars plana region to uniformly illuminate the vitreous body. A processor is in communication with the light emitter. A setting of the light emitter is controllable via the processor or analog electronics in such a construction.
The ophthalmic visualization tool in accordance with another implementation includes an optical lens, a frame, a flange, and a plurality of red, green, and blue (RGB) LEDs. The lens is configured for viewing an anterior, middle, or posterior portion of the vitreous body. The frame has an annular body and a neck portion, with the latter being configured to support a perimeter edge of the lens. The flange in this non-limiting/representative construction of the tool has a frustoconical shape inclusive of a first end connected to the neck portion and a second end configured to rest on a scleral surface of the eye at the pars plana region thereof. The LEDs are arranged in an annular arrangement that is connected to the flange in proximity to the second end. The LEDs in the annular arrangement directs light into a vitreous cavity of the eye through the scleral surface, at the pars plana region, to uniformly illuminate the vitreous body.
The above-described features and advantages and other possible features and advantages of the present disclosure will be apparent from the following detailed description of the best modes for carrying out the disclosure when taken in connection with the accompanying drawings.
The solutions of the present disclosure may be modified or presented in alternative forms. Representative embodiments are shown by way of example in the drawings and described in detail below. However, inventive aspects of this disclosure are not limited to the disclosed embodiments. Rather, the present disclosure is intended to cover alternatives falling within the scope of the disclosure as defined by the appended claims.
Referring to the drawings, wherein like reference numbers refer to like components, a representative visualization procedure 10 as illustrated in
The visualization procedure 10 could be performed in conjunction with a stereoscopic biomicroscope (“slit-lamp”) 30. As appreciated by those skilled in the art, the slit lamp 30 is typically configured to emit a light beam with clinician-controllable characteristics when viewing the interior of the eye 26. During the visualization procedure, e.g., in preparation for or concurrent with a vitreolysis or vitrectomy surgery, and with or without the slit-lamp 30, the clinician can place the visualization tool 14 directly on the eye 26. The clinician is then able to view the vitreous 24 of
In one or more embodiments, the clinician may interact with the light emitter(s) 16 to selectively adjust a setting thereof. This action may occur in response to a user input signal 32, e.g., using a voice command, foot pedal activation, or use of a button, touch screen, etc. The processor 20 may receive the user input signal 32 and respond by changing one or more settings of the light emitter(s) 16, such as by adjusting a color and/or intensity setting. This may be accomplished via transmission of an electronic control signal (CCE) 132 from the processor 20 to associated drive circuitry of the light emitters 16.
By way of a non-limiting example, the light emitters 16 shown schematically in
Referring now to
In the exemplary implementation of the laser vitreolysis surgery 100, the laser beam 33 is directed into the vitreous 24 through the cornea 36 and lens 38 of the eye 26 as shown. The vitreous chamber 43 exists between the lens 38 located at the anterior of the eye 26 and the optic nerve 45 located at the posterior of the eye 26, with the vitreous 24 filling the vitreous chamber 43 in contact with the retina 50. The laser beam 33 thus passes through the vitreous 24 to fall incident upon the floaters 124, with energy imparted by the laser beam 33 ultimately reducing or evaporating the floaters 124 as understood in the art.
Because the floaters 124 are dynamic phase objects, the floaters 124 can be challenging to properly visualize and distinguish from the surrounding vitreous 24. To that end, the light emitters 16 are placed as shown allow emitted light 16L to pass through the sclera 40 and choroid 42 into the vitreous chamber 43. As described in detail below with particular reference to
Further with respect to positioning of the light emitters 16, the eye 26 when viewed from the side as in
Referring to
A flange 64 is connected to or formed integrally with the annular body 62, e.g., at a narrowed interface or neck portion 75. The neck portion 75 could be integral with the set of tabs 66 and thus configured to support the perimeter edge 63E of the optical lens 63. The flange 64 has a first end E1 and a second end E2. The first end E1 is connected to the annular body 62. The second end E2 is configured to rest on the sclera 40 of the patient's eye 26. In this embodiment, the light emitter 16 is connected to the flange 64 proximate the second end E2 such that the light emitter 16 is configured to direct light 16L into the vitreous cavity 43. This occurs through the intervening tissue of the sclera 40 and choroid 42, and thus is trans-scleral.
At the specific location proximate the pars plana region 46, the emitted light 16L uniformly illuminates the vitreous 24 without undesirable scattering or reflection. The clinician is thus better able to track the floaters 124 as they move within the vitreous 24. The second end E2 rests on the sclera 40. Therefore, the flange 64, or at least the distal end surface 65 thereof, should be constructed of materials that would be comfortable when temporarily in contact with the eye 26. Exemplary materials include synthetic polymers such as polymer polymethyl methacrylate (PMMA), rubberized or coated plastics, silicone rubber, etc.
Referring now to
As illustrated in
Embodiments of the present disclosure are described herein. The disclosed embodiments are merely examples, however, and thus other embodiments can take various and alternative forms. The drawings are not necessarily to scale. Some features could be exaggerated or minimized to show details of particular components. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for teaching one skilled in the art to variously employ the present disclosure.
Certain terminology may be used in the following description for the purpose of reference only, and thus are not intended to be limiting. For example, terms such as “above” and “below” refer to directions in the drawings to which reference is made. Terms such as “front,” “back,” “fore,” “aft,” “left,” “right,” “rear,” and “side” describe the orientation and/or location of portions of the components or elements within a consistent but arbitrary frame of reference which is made clear by reference to the text and the associated drawings describing the components or elements under discussion. Moreover, terms such as “first,” “second,” “third,” and so on may be used to describe separate components. Such terminology may include the words specifically mentioned above, derivatives thereof, and words of similar import.
The detailed description and the drawings are supportive and descriptive of the disclosure, but the scope of the disclosure is defined solely by the claims. While some of the best modes and other embodiments for carrying out the claimed disclosure have been described in detail, various alternative designs and embodiments exist for practicing the disclosure defined in the appended claims.
The present application claims the benefit of priority to U.S. Provisional Application No. 63/520,121 filed on Aug. 17, 2023, which is hereby incorporated by reference in its entirety for all purposes.
Number | Date | Country | |
---|---|---|---|
63520121 | Aug 2023 | US |